• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌中微小RNA依赖的转录调控

MicroRNA-dependent regulation of transcription in non-small cell lung cancer.

作者信息

Molina-Pinelo Sonia, Gutiérrez Gabriel, Pastor Maria Dolores, Hergueta Marta, Moreno-Bueno Gema, García-Carbonero Rocío, Nogal Ana, Suárez Rocío, Salinas Ana, Pozo-Rodríguez Francisco, Lopez-Rios Fernando, Agulló-Ortuño Maria Teresa, Ferrer Irene, Perpiñá Asunción, Palacios José, Carnero Amancio, Paz-Ares Luis

机构信息

Molecular Oncology and New Therapies Group. Instituto de Biomedicina de Sevilla (IBIS) (HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain.

Genetic Department, Universidad de Sevilla, Seville, Spain.

出版信息

PLoS One. 2014 Mar 13;9(3):e90524. doi: 10.1371/journal.pone.0090524. eCollection 2014.

DOI:10.1371/journal.pone.0090524
PMID:24625834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3953115/
Abstract

Squamous cell lung cancer (SCC) and adenocarcinoma are the most common histological subtypes of non-small cell lung cancer (NSCLC), and have been traditionally managed in the clinic as a single entity. Increasing evidence, however, illustrates the biological diversity of these two histological subgroups of lung cancer, and supports the need to improve our understanding of the molecular basis beyond the different phenotypes if we aim to develop more specific and individualized targeted therapy. The purpose of this study was to identify microRNA (miRNA)-dependent transcriptional regulation differences between SCC and adenocarcinoma histological lung cancer subtypes. In this work, paired miRNA (667 miRNAs by TaqMan Low Density Arrays (TLDA)) and mRNA profiling (Whole Genome 44 K array G112A, Agilent) was performed in tumor samples of 44 NSCLC patients. Nine miRNAs and 56 mRNAs were found to be differentially expressed in SCC versus adenocarcinoma samples. Eleven of these 56 mRNA were predicted as targets of the miRNAs identified to be differently expressed in these two histological conditions. Of them, 6 miRNAs (miR-149, miR-205, miR-375, miR-378, miR-422a and miR-708) and 9 target genes (CEACAM6, CGN, CLDN3, ABCC3, MLPH, ACSL5, TMEM45B, MUC1) were validated by quantitative PCR in an independent cohort of 41 lung cancer patients. Furthermore, the inverse correlation between mRNAs and microRNAs expression was also validated. These results suggest miRNA-dependent transcriptional regulation differences play an important role in determining key hallmarks of NSCLC, and may provide new biomarkers for personalized treatment strategies.

摘要

鳞状细胞肺癌(SCC)和腺癌是非小细胞肺癌(NSCLC)最常见的组织学亚型,传统上在临床上将它们作为一个整体进行治疗。然而,越来越多的证据表明这两种肺癌组织学亚组具有生物学多样性,并且支持如果我们旨在开发更具特异性和个体化的靶向治疗,就需要加深对不同表型之外的分子基础的理解。本研究的目的是确定SCC和腺癌组织学肺癌亚型之间基于微小RNA(miRNA)的转录调控差异。在这项工作中,对44例NSCLC患者的肿瘤样本进行了配对miRNA(通过TaqMan低密度阵列(TLDA)检测667种miRNA)和mRNA谱分析(全基因组44K阵列G112A,安捷伦)。发现9种miRNA和56种mRNA在SCC与腺癌样本中差异表达。这56种mRNA中的11种被预测为在这两种组织学条件下差异表达的miRNA的靶标。其中,6种miRNA(miR-149、miR-205、miR-375、miR-378、miR-422a和miR-708)和9个靶基因(CEACAM6、CGN、CLDN3、ABCC3、MLPH、ACSL5、TMEM45B、MUC1)在41例肺癌患者的独立队列中通过定量PCR得到验证。此外,mRNA与miRNA表达之间的负相关也得到了验证。这些结果表明基于miRNA的转录调控差异在确定NSCLC的关键特征中起重要作用,并可能为个性化治疗策略提供新的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/90cfdb95b48c/pone.0090524.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/3e70509857a4/pone.0090524.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/b2e3edd10b97/pone.0090524.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/041536dc7098/pone.0090524.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/5f192e81a49a/pone.0090524.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/16ce16d9838e/pone.0090524.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/310637c6a066/pone.0090524.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/4d2e996cd11b/pone.0090524.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/90cfdb95b48c/pone.0090524.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/3e70509857a4/pone.0090524.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/b2e3edd10b97/pone.0090524.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/041536dc7098/pone.0090524.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/5f192e81a49a/pone.0090524.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/16ce16d9838e/pone.0090524.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/310637c6a066/pone.0090524.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/4d2e996cd11b/pone.0090524.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75c6/3953115/90cfdb95b48c/pone.0090524.g008.jpg

相似文献

1
MicroRNA-dependent regulation of transcription in non-small cell lung cancer.非小细胞肺癌中微小RNA依赖的转录调控
PLoS One. 2014 Mar 13;9(3):e90524. doi: 10.1371/journal.pone.0090524. eCollection 2014.
2
miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.miRNAs 表达谱区分肺鳞癌与腺癌亚型。
J Cancer Res Clin Oncol. 2012 Oct;138(10):1641-50. doi: 10.1007/s00432-012-1240-0. Epub 2012 May 22.
3
Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.鉴定肺鳞癌和肺腺癌之间差异表达的 microRNAs。
Mol Med Rep. 2013 Aug;8(2):456-62. doi: 10.3892/mmr.2013.1517. Epub 2013 Jun 11.
4
Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.转录组研究揭示了 miR-146a-5p 在非小细胞肺癌(NSCLC)细胞中作为肿瘤抑制因子的作用。
RNA Biol. 2019 Dec;16(12):1721-1732. doi: 10.1080/15476286.2019.1657351. Epub 2019 Aug 23.
5
Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.微小RNA在非小细胞肺癌中的表达及其与临床病理特征的关联。
Tumour Biol. 2015 Mar;36(3):1603-12. doi: 10.1007/s13277-014-2755-6. Epub 2014 Nov 11.
6
Prognostic value of microRNA expression in operable non-small cell lung cancer patients.可手术非小细胞肺癌患者中 miRNA 表达的预后价值。
Br J Cancer. 2014 Feb 18;110(4):991-1000. doi: 10.1038/bjc.2013.786. Epub 2014 Jan 21.
7
Clinical evaluation of microRNA expression profiling in non small cell lung cancer.非小细胞肺癌中 microRNA 表达谱的临床评估。
Lung Cancer. 2013 Sep;81(3):388-396. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.
8
Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.BCAR1 表达增加预示着多中心患者非小细胞肺癌的不良预后。
Ann Surg Oncol. 2013 Dec;20 Suppl 3(0 3):S701-8. doi: 10.1245/s10434-013-3184-2. Epub 2013 Aug 1.
9
MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.MiR-205和MiR-375微小RNA检测用于在肺癌活检中区分鳞状细胞癌和腺癌。
J Thorac Oncol. 2015 Mar;10(3):446-53. doi: 10.1097/JTO.0000000000000423.
10
Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.非小细胞肺癌血清和组织中miR-181b-5p和miR-486-5p的异常表达
Gene. 2016 Oct 15;591(2):338-43. doi: 10.1016/j.gene.2016.06.014. Epub 2016 Jun 9.

引用本文的文献

1
Dysregulation of the DRAIC/SBK1 Axis Promotes Lung Cancer Progression.DRAIC/SBK1轴的失调促进肺癌进展。
Diagnostics (Basel). 2024 Oct 5;14(19):2227. doi: 10.3390/diagnostics14192227.
2
The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer.跨膜蛋白(TMEM)及其在癌症细胞增殖、迁移、侵袭和上皮-间质转化中的作用。
Front Oncol. 2023 Oct 23;13:1244740. doi: 10.3389/fonc.2023.1244740. eCollection 2023.
3
Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?

本文引用的文献

1
Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples.非小细胞肺癌的同时多抗体染色增强了诊断准确性,尤其是在小组织样本中。
PLoS One. 2013;8(2):e56333. doi: 10.1371/journal.pone.0056333. Epub 2013 Feb 13.
2
A novel method for finding non-small cell lung cancer diagnosis biomarkers.一种用于寻找非小细胞肺癌诊断生物标志物的新方法。
BMC Med Genomics. 2013;6 Suppl 1(Suppl 1):S11. doi: 10.1186/1755-8794-6-S1-S11. Epub 2013 Jan 23.
3
Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
细胞外囊泡与癌症多药耐药性:不良的细胞间信使?
Life (Basel). 2023 Jul 27;13(8):1633. doi: 10.3390/life13081633.
4
Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition.新型重组 RNA 在药物代谢与处置中转录后基因调控研究中的最新进展。
Curr Drug Metab. 2023;24(3):175-189. doi: 10.2174/1389200224666230425232433.
5
The Double Face of miR-708: A Pan-Cancer Player with Dissociative Identity Disorder.miR-708 的双重面孔:一个具有分离性身份障碍的泛癌“玩家”。
Genes (Basel). 2022 Dec 16;13(12):2375. doi: 10.3390/genes13122375.
6
Hsa-miR-422a Originated from Short Interspersed Nuclear Element Increases Expression by Collaborating with NF-E2.Hsa-miR-422a 来源于短散在核元件,通过与 NF-E2 协作增加表达。
Mol Cells. 2022 Jul 31;45(7):465-478. doi: 10.14348/molcells.2022.2158. Epub 2022 Apr 20.
7
Reference Genes for qPCR-Based miRNA Expression Profiling in 14 Human Tissues.用于 qPCR 检测 miRNA 表达谱的 14 个人类组织参考基因。
Med Princ Pract. 2022;31(4):322-332. doi: 10.1159/000524283. Epub 2022 Mar 30.
8
miR-4731-5p Enhances Apoptosis and Alleviates Epithelial-Mesenchymal Transition through Targeting RPLP0 in Non-Small-Cell Lung Cancer.miR-4731-5p通过靶向RPLP0增强非小细胞肺癌细胞凋亡并减轻上皮-间质转化
J Oncol. 2022 Mar 17;2022:3793318. doi: 10.1155/2022/3793318. eCollection 2022.
9
CircNT5E/miR-422a: a new circRNA-based ceRNA network in glioblastoma.环状核苷酸酶5E/微小RNA-422a:胶质母细胞瘤中基于新型环状RNA的竞争性内源RNA网络
Transl Cancer Res. 2019 Mar;8(Suppl 2):S106-S109. doi: 10.21037/tcr.2018.11.13.
10
Expression of and among Iranian Patients with Lung Cancer and Their Relationship with Smoking and Infection.伊朗肺癌患者中[具体内容缺失]的表达及其与吸烟和[具体内容缺失]感染的关系。
Cell J. 2021 Dec;23(7):723-729. doi: 10.22074/cellj.2021.7704. Epub 2021 Dec 29.
两个 microRNA panel 区分支气管刷检标本中的三种肺癌亚型。
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1160-7. doi: 10.1164/rccm.201203-0534OC. Epub 2012 Oct 4.
4
Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies.血浆和肺泡灌洗液中 miRNA 特征与呼吸道疾病的关系。
Dis Markers. 2012;32(4):221-30. doi: 10.3233/DMA-2011-0882.
5
Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities.肺鳞状细胞癌:分子亚型与治疗机会。
Clin Cancer Res. 2012 May 1;18(9):2443-51. doi: 10.1158/1078-0432.CCR-11-2370. Epub 2012 Mar 8.
6
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.癌症统计数据,2011 年:消除社会经济和种族差异对癌症过早死亡的影响。
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.
7
Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.基于 microRNA 表达谱对经胸针吸活检标本进行非小细胞肺癌的分类。
Chest. 2011 Nov;140(5):1305-1311. doi: 10.1378/chest.11-0708. Epub 2011 May 26.
8
miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes.miRWalk--数据库:通过“游走”三个基因组的基因来预测可能的 miRNA 结合位点。
J Biomed Inform. 2011 Oct;44(5):839-47. doi: 10.1016/j.jbi.2011.05.002. Epub 2011 May 14.
9
Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers.非小细胞肺癌的基因表达谱:生存预测和新的生物标志物。
Oncology. 2010;79(3-4):283-92. doi: 10.1159/000322116. Epub 2011 Mar 16.
10
Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.在缺乏形态学分化的非小细胞肺癌活检标本的分类:包含 TTF-1、napsin A、p63 和 CK5/6 的免疫组织化学组合的应用。
Am J Surg Pathol. 2011 Jan;35(1):15-25. doi: 10.1097/PAS.0b013e3182036d05.